ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 64 filers reported holding ANACOR PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 2.16 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $1,657,000 | -99.8% | 31 | -99.6% | 0.00% | -100.0% |
Q4 2015 | $915,960,000 | -27.9% | 8,108 | -24.9% | 0.00% | -33.3% |
Q3 2015 | $1,271,150,000 | +156.2% | 10,799 | +68.5% | 0.00% | +200.0% |
Q2 2015 | $496,249,000 | +126.6% | 6,409 | +69.3% | 0.00% | 0.0% |
Q1 2015 | $219,020,000 | -43.4% | 3,786 | -68.4% | 0.00% | 0.0% |
Q4 2014 | $387,000,000 | -8.8% | 12,000 | -30.8% | 0.00% | – |
Q3 2014 | $424,139,000 | +47.6% | 17,333 | +6.9% | 0.00% | – |
Q2 2014 | $287,368,000 | +45.4% | 16,208 | +35.1% | 0.00% | – |
Q1 2014 | $197,640,000 | +3490.8% | 12,000 | +3558.5% | 0.00% | – |
Q4 2013 | $5,504,000 | -91.2% | 328 | -97.1% | 0.00% | – |
Q2 2013 | $62,854,000 | – | 11,244 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RHO CAPITAL PARTNERS INC | 1,067,892 | $125,702,000 | 41.75% |
VHCP Management, LLC | 1,178,474 | $138,718,000 | 35.56% |
Palo Alto Investors LP | 2,579,154 | $303,592,000 | 14.60% |
Baker Brothers Advisors | 4,135,412 | $486,779,000 | 4.50% |
APIS CAPITAL ADVISORS, LLC | 23,000 | $2,708,000 | 3.75% |
EMORY UNIVERSITY | 11,096 | $1,306,000 | 3.64% |
Atika Capital Management LLC | 61,000 | $7,180,000 | 3.52% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 488,912 | $57,550,000 | 2.78% |
Segantii Capital Management Ltd | 100,000 | $11,134,000 | 2.55% |
NEXT CENTURY GROWTH INVESTORS LLC | 428,835 | $50,478,000 | 2.10% |